Cardinal Health (CAH) Stock Forecast & Price Target

$234.92 +3.68 (+1.59%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$235.16 +0.24 (+0.10%)

As of 08/14/2026 07:34 PM Eastern

Compare

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
0

Hold
3

Buy
15

Based on 18 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 3 have given a hold rating, and 15 have given a buy rating for CAH.

Consensus Price Target

$265.93
13.20% Upside

According to the 18 analysts' twelve-month price targets for Cardinal Health, the average price target is $265.93. The highest price target for CAH is $292.00, while the lowest price target for CAH is $208.00. The average price target represents a forecasted upside of 13.20% from the current price of $234.92.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Analyst Ratings Over Time

Type	Current Forecast 8/15/25 to 8/15/26	1 Month Ago 7/16/25 to 7/16/26	3 Months Ago 5/17/25 to 5/17/26	1 Year Ago 8/15/24 to 8/15/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	15 Buy rating(s)	12 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$265.93	$249.13	$241.80	$163.20
Forecasted Upside	13.20% Upside	8.85% Upside	23.94% Upside	9.17% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Healthcare Companies	Broader Market
Consensus Rating Score	2.83	2.29	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	13.20% Upside	785.24% Upside	11.05% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/13/2026	TD Cowen 3 of 5 stars	Charles Rhyee Not Rated	Boost Target	Buy	$275.00 ➝ $280.00	+20.56%
8/13/2026	Barclays 3 of 5 stars	Glen Santangelo Not Rated	Boost Target	Overweight	$258.00 ➝ $275.00	+17.43%
8/13/2026	JPMorgan Chase & Co. 3 of 5 stars	Lisa Gill 4 of 5 stars	Boost Target	Neutral	$215.00 ➝ $260.00	+12.22%
8/12/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$255.00 ➝ $265.00	+11.53%
8/12/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elizabeth Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$270.00	+12.46%
8/12/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$274.00 ➝ $280.00	+16.63%
8/12/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Valiquette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$240.00 ➝ $250.00	+4.13%
8/12/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$265.00 ➝ $280.00	+18.01%
8/12/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$245.00 ➝ $277.00	+15.38%
8/12/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Coldwell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$251.00 ➝ $274.00	+14.13%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
8/11/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$292.00	+21.63%
8/5/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Buy (B) ➝ Buy (B+)
7/2/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Lutz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$240.00 ➝ $260.00	+8.08%
6/12/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
4/28/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Smock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
2/11/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$232.00 ➝ $248.00	+12.31%
1/22/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Tanquilut Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$220.00 ➝ $270.00	+29.34%
11/18/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$195.00 ➝ $208.00	+0.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:58 PM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 10, 2026. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

The company recently reported a significant increase in revenue, showing an 11.0% growth year-over-year, indicating strong business performance and potential for future profitability.
Cardinal Health, Inc. has set its FY 2026 guidance at an EPS of 10.700-10.80, with analysts expecting an EPS of 10.77 for the current fiscal year, suggesting stable earnings prospects.
The current stock price is around $255, reflecting positive market sentiment and potential for appreciation as the company continues to perform well.
Cardinal Health, Inc. has increased its quarterly dividend to $0.5158 per share, which is a positive signal for income-focused investors, indicating a commitment to returning value to shareholders.
With a payout ratio of 31.50%, the company maintains a healthy balance between returning profits to shareholders and reinvesting in growth, which can be attractive for long-term investors.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

The company has reported a negative return on equity of 92.61%, which may raise concerns about its efficiency in generating profits from shareholders' equity.
Despite revenue growth, Cardinal Health, Inc. had a net margin of only 0.62%, indicating that profitability may be a concern and could affect future earnings.
Analyst ratings show a mix of opinions, with some downgrades in price targets, which could signal uncertainty in the stock's future performance.
Market volatility and economic conditions can impact the healthcare sector, and any adverse changes could affect Cardinal Health, Inc.'s operations and financial results.
Investors should consider the competitive landscape in the healthcare industry, as increased competition could pressure margins and growth prospects for Cardinal Health, Inc.

CAH Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $265.93, with a high forecast of $292.00 and a low forecast of $208.00.

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 3 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CAH shares.

According to analysts, Cardinal Health's stock has a predicted upside of 13.20% based on their 12-month stock forecasts.

Over the previous 90 days, Cardinal Health's stock had 2 downgrades and 1 upgrade by analysts.

Cardinal Health has been rated by research analysts at Bank of America, Barclays, Citigroup, Evercore, JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Robert W. Baird, TD Cowen, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Cardinal Health more than other "healthcare" companies. The consensus rating for Cardinal Health is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cardinal Health Recommendations

This page (NYSE:CAH) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target